1. Short title This Act may be cited as the Ovarian and Cervical Cancer Awareness Act of 2017 . 2. Findings The Congress finds as follows: (1) Ovarian and cervical cancers are among the most destructive gynecological forms of cancer. (2) Ovarian cancer causes more deaths than any other cancer of the female reproductive system. (3) The main methods used to screen for ovarian cancer are pelvic exams, ultrasounds, Pap smears, and blood tests such as cancer antigen-125 ( CA–125 ). (4) Most women who develop invasive cervical cancer have not had regular cervical cancer screening. 3. Purposes The purposes of this Act are the following: (1) Raising awareness about ovarian and cervical cancers. (2) Raising awareness about the importance (especially for those women who have a family history of cancer or are otherwise at higher risk) of frequent consultation with a physician and the possibility of screening (through tests such as pelvic exams, ultrasounds, Pap smears, and blood tests such as cancer antigen-125) for ovarian, cervical, and other gynecologic cancer. (3) Promotion of early detection methods for ovarian and cervical cancer. (4) Ensuring that special emphasis is given to ovarian and cervical cancer under the public awareness campaign carried out by the Secretary of Health and Human Services under section 317P(d) of the Public Health Service Act ( 42 U.S.C. 247b–17(d) ; commonly referred to as Johanna’s Law ). 4. Increasing public awareness of ovarian and cervical cancer Section 317P(d) of the Public Health Service Act ( 42 U.S.C. 247b–17(d) ; commonly referred to as Johanna’s Law ) is amended— (1) in paragraph (1)(A), by striking with respect to gynecologic cancers and inserting with respect to ovarian, cervical, and other gynecologic cancers